The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Nikkei snaps 7-day losing streak helped by China's stimulus hopes

Wed, 15th May 2019 08:05

* Gains may be short-lived - analyst

* Takeda Pharma, Nissan sink after earnings shock

* Mitsubishi Estate jumps on share buyback, governancereform

By Hideyuki Sano and Ayai Tomisawa

TOKYO, May 15 (Reuters) - Japan's Nikkei ended higher inchoppy trade on Wednesday, snapping a seven-day losing streak,as expectations that China could roll out fresh stimulus to propup a slowing economy supported stocks in the region.

The Nikkei share average ended 0.6% higher at21,288.56, after trading in negative territory in the morning.It had dropped for seven straight days.

The broader Topix, which hit a four-month low theprevious day, rose 0.6% to 1,544.15.

"The market turned around on hopes that China will launchstimulus measures to tackle the weak economy, but the gains maybe short-lived as it was just hopes at this point," said YutakaMiura, a senior technical analyst at Mizuho Securities.

U.S. futures also rose 0.2% indicating a positiveopen for U.S. stocks later in the day.

Exporters gained with Sony Corp up 4%, Subaru Corprising 2.7% and Hitachi Ltd 2.6% higher.

Meanwhile, Japanese corporate earnings disappointed themarket, with net profits falling almost 5.0% from a year earlierin January-March, according to Okasan Securities.

Takeda Pharmaceutical plunged 7.8% after Japan'sbiggest drugmaker forecast an unexpected operating loss for thecurrent year due to costs associated with the $59 billionpurchase of Shire Plc.

That weighed on Tokyo Stock Exchange's drugmaker subindex3%, making it the worst performer.

Nissan Motor slumped 6.5% after the carmakerforecast the weakest profit outlook in more than a decade.

"The earnings results suggested that the company is in muchworse shape than I have imagined," said Hiroshi Masushima,market analyst at Monex Securities.

The carmaker, hit by former chairman Carlos Ghosn's arrestlast year and troubles at its North American business, also saidits dividend will be cut about 30% in another blow to investorsas its hefty payouts have been the only major attraction.

H2O Retailing stumbled 11% as the mid-tierdepartment store operator posted weak earnings and guidance.

On the upside, Mitsubishi Estate jumped 9.2% afterthe real estate developer announced its first share buyback anda plan to abolish anti-takeover steps.(Editing by Sam Holmes)

More News
6 Sep 2019 07:54

UPDATE 1-Sumitomo Dainippon Pharma investing $3 bln in Swiss Roivant in overseas push

* Dainippon to buy 10% stake in Roivant and interests in 5 units * Schizophrenia treatment Latuda to lose US exclusivity in 2023 * Japan pharma firms grapple with declining Dainippon

Read more
14 Aug 2019 06:45

UPDATE 1-Germany's Stada 'very selective' on acquisitions - CEO Goldschmidt

FRANKFURT, Aug 14 (Reuters) - German generic drugmaker Stada will be careful about buying businesses and companies outright, and for now will focus mainly on striking production and development we

Read more
17 Jul 2019 17:55

Takeda kicks off sale of Western European drugs - sources

By Arno Schuetze and Pamela Barbaglia FRANKFURT/LONDON, July 17 (Reuters) - Japan's Takeda Pharmaceutical Co has reached out to prospective bidders for a portfolio of drugs for sale in

Read more
16 May 2019 18:35

Japan's Takeda expects binding offers for Latam business by end of May -sources

By Tatiana Bautzer SAO PAULO, May 16 (Reuters) - Japan's Takeda Pharmaceutical Co expects to receive binding offers for its Latin American business by the end of May, three sources of a

Read more
15 May 2019 04:04

Nikkei hobbled by trade worries, disappointing earnings

* Nikkei down slightly after 7 losing sessions * Uncertainties over U.S.-China standoff keep investors on edge * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi -

Read more
14 May 2019 07:56

UPDATE 1-Japan's Takeda forecasts 193 bln yen annual operating loss on Shire deal

* 193 bln Y op loss forecast this yr vs 227.5 bln profit view of analysts * Shire acquisition made Takeda one of the world's most indebted drugmakers (Adds details of results, May 14 -

Read more
14 May 2019 07:39

Japan's Takeda expects annual loss on Shire deal

TOKYO, May 14 (Reuters) - Takeda Pharmaceutical Co forecast on Tuesday it would have an operating loss in the current financial year, as it books costs associated with the multibillion-dollar an a

Read more
9 May 2019 00:38

UPDATE 1-Novartis buys Takeda's dry eye drug for $3.4 bln

May 8 (Reuters) - Swiss drugmaker Novartis AG said on Wednesday it agreed to acquire Takeda Pharmaceutical Company Ltd's dry eye drug Xiidra for $3.4 billion, as well as potential milestone of

Read more
1 Feb 2019 06:07

Japan's Takeda posts 28 pct rise in Q3 operating profit

TOKYO, Feb 1 (Reuters) - Takeda Pharmaceutical Co Ltd on Friday posted a 27.9 percent rise in third-quarter operating profit, supported by strong sales of its drugs for bowel disease and multiple

Read more
22 Jan 2019 02:46

Nikkei dips as global growth concerns sap risk appetite

* IMF cuts global growth forecasts * Companies with big China exposure fall * Totech soars after raising earnings forecast By Ayai Tomisawa TOKYO, Jan 22 (Reuters) - in

Read more
8 Jan 2019 13:54

MARKET ANALYSIS: Optimism About Trade Talks May Generate Continued Buying Interest

WASHINGTON (Alliance News) - The major US index futures are pointing to a higher opening on Tuesday, with stocks likely to extend the strong upward move seen over the two previous about trade the

Read more
8 Jan 2019 08:58

Asian Shares Mixed Despite US-China Trade Deal Optimism

CANBERA (Alliance News) - Asian stocks ended mixed on Tuesday despite optimism over US-China trade talks as US officials held a second day of trade talks with Chinese counterparts in second day of

Read more
8 Jan 2019 07:39

Takeda takes control of Shire

(Sharecast News) - Takeda Pharmaceutical has taken full control of Shire after the legal particulars of its cash and share offer were completed.

Read more
7 Jan 2019 04:29

Takeda unlikely to sell OTC drug business -CEO

(Adds quote, other details) TOKYO, Jan 7 (Reuters) - Takeda Pharmaceutical is unlikely to sell its over-the-counter (OTC) drug business even amid pressure to improve its finances as it a a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.